The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meetings and Open Offer

25 Jul 2016 12:34

RNS Number : 1376F
Frontier Resources International
25 July 2016
 

25 July 2016 

Frontier Resources International plc

('Frontier Resources International' or the 'Company') to be renamed Concepta PLC

RESULT OF GENERAL MEETINGS AND OPEN OFFER

Result of Meetings

Frontier Resources International plc (AIM:FRI) announces that, at the General Meetings of the Company held earlier today, all resolutions were duly passed.

The Share Consolidation, whereby every 250 existing ordinary shares of 0.01p will be consolidated into 1 new ordinary share of 2.5p ("New Ordinary Shares"), and such that the 5,200,000,000 existing ordinary shares of 0.01p are consolidated into 20,800,000 New Ordinary Shares will take place at 5.00pm this evening.

The change of the Company's name to Concepta PLC (AIM: CPT), a pioneering UK healthcare company that has developed proprietary products and a platform, which targets the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility, will become effective upon the registration of the Company's change of name at Companies House, and is expected later this afternoon. A further announcement will be made in due course.

Additionally, the following proposals become unconditional in all respects upon Admission of the Enlarged Share Capital to trading on AIM, which is expected to occur at 8.00 a.m. on Tuesday 26 July 2016:

· the acquisition by the Company of the entire issued share capital of Concepta Diagnostics Limited, resulting in the issue of 30,343,950 New Ordinary Shares;

· the issue of 32,050,342 New Ordinary Shares under the Firm Placing, 1,373,330 New Ordinary Shares under the Subscription, 10,833,333 New Ordinary Shares under the Debt Conversion, 13,759,618 New Ordinary Shares under the Conditional Placing with clawback under the Open Offer (see below under "Open Offer"); and

· Erik Henau and Dr Mark Wyatt join the Board as Chief Executive and Non-Executive Director respectively.

The Enlarged Ordinary Share Capital of the Company, comprising 109,160,573 New Ordinary Shares, will trade under the ISIN GB00BYZ2R301.

Open Offer

The Company received valid applications under the Open Offer from Qualifying Shareholders in respect of 26,987,695 New Ordinary Shares, representing 196% of the 13,759,618 shares available under the Open Offer. As a result, excess applications have been scaled back in accordance with the Terms & Conditions of the Open Offer. Qualifying Shareholders who subscribed for excess shares will be notified of their allocations shortly by post.

The Offer Shares have been clawed back from the conditional placees, as set out in the Company's announcement of 7 July 2016.

 

 

 

Terms defined in the Admission Document (which was issued on 7 July 2016) have the same meaning in this announcement. A copy of the Admission Document can also be viewed on the Company's website.

Following Admission of all the shares referred to above, the shares held by members of the Concert Party, and as a percentage of the Enlarged Share Capital will be as follows:

 

Name

Number of Shares

% of Enlarged Share Capital

Steven Lee

2,412,050

2.21

Michael Catt

2,240,100

2.05

Zhang Zhi Gang

2,461,783

2.26

Robert Porter

2,528,450

2.32

Angel Co Fund

11,668,267

10.69

David Evans

2,834,033

2.60

Neil McArthur

1,999,750

1.83

Clare Hughes

1,999,750

1.83

Andrew Parker

1,333,800

1.22

Steven Lister/ Debbie Heath

1,000,350

0.92

David Groves

666,900

0.61

Alan Halsall

666,900

0.61

David Gare

266,950

0.24

Richard Faulkner

66,500

0.06

Adam Reynolds

1,155,555

1.06

Total

33,301,138

30.51

 

In addition, the holdings of other directors following their previously announced participation in the Open Offer are as follows:

Name No of shares held % of Enlarged Share Capital

Barbara Spurrier 246,057* 0.23%

* 100,952 of these shares are held by CFPro Limited, a company with which Barbara Spurrier is connected.

Buyback of deferred shares

The Company has now bought back all the Deferred Shares of 0.9p each and all of the "A" Deferred Shares of 0.09p each, and all such shares have now been cancelled.

Total voting rights

Following the issue of the new Ordinary Shares, the Company's issued share capital consists of 109,160,573 Ordinary Shares, with voting rights. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

-ENDS-

 

Enquiries:

The Company

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

 

Beaufort Securities Limited (Broker)

Jon Belliss

Tel: +44 (0)20 7382 8300

 

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess/ Josh Cole

Tel: +44 (0) 7748 843 871

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFXSADEKEFF
Date   Source Headline
27th Sep 20187:00 amRNSInterim Results
21st Sep 20189:47 amRNSHolding(s) in Company
28th Aug 20187:00 amRNSHolding(s) in Company
13th Aug 201812:55 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSHolding(s) in Company
9th Aug 201812:15 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSOversubscribed placing raises £2,000,000
17th Jul 20187:00 amRNSBoard Changes
14th Jun 201810:22 amRNSResult of AGM
22nd May 20185:13 pmRNSNotice of AGM
1st May 20187:00 amRNSFinal Results
26th Apr 201810:00 amRNSLogistics deal with major Chinese player SinoPharm
9th Apr 20188:25 amRNSConcepta manufacturing site achieves certification
29th Mar 20187:00 amRNSConcepta pre-launch myLotus in the UK
8th Mar 20187:00 amRNSmyLotus obtains approval to commence trial in UK
20th Feb 20187:00 amRNSLaunch of myLotus app in China
16th Feb 20187:00 amRNSTwo Senior Appointments and Grant of Options
15th Feb 20187:00 amRNSConcepta signs marketing contract in China
2nd Feb 20184:17 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSResults of Chinese hospital evaluations of myLotus
2nd Jan 201812:52 pmRNSChange of Broker
22nd Dec 201711:30 amRNSTrading update
14th Dec 20177:00 amRNSAssembly held in Shanghai to showcase myLotus
30th Nov 20173:05 pmRNSDirector/PDMR Shareholding
29th Nov 20179:02 amRNSHolding(s) in Company
13th Nov 20177:02 amRNSAppointment of Joint Corporate Broker
13th Nov 20177:01 amRNSOversubscribed equity fundraising of £2,000,000
13th Nov 20177:00 amRNSSales Order
6th Nov 201712:53 pmRNSTrading and Order Update
16th Oct 20177:00 amRNSmyLotus Fertility Product - China Update
19th Sep 20177:00 amRNSInterim Results
23rd Aug 201712:00 pmRNSCorporate Update
26th Jun 20177:00 amRNSDirector Shareholding
14th Jun 201712:00 pmRNSResult of AGM
13th Jun 20177:00 amRNSFirst Sales Order China and Trading Update
24th May 20174:58 pmRNSNotice of AGM
10th May 20177:00 amRNSFirst distributor agreement in China
26th Apr 20177:00 amRNSFinal Results
29th Mar 201710:00 amRNSUK Investor Show 2017
28th Mar 20177:00 amRNSDirectorate Changes
14th Feb 20171:45 pmRNSChange of Registered Office
7th Feb 20177:00 amRNSConcepta signs agreement with Selective Antibodies
9th Jan 20177:00 amRNSConcepta achieves ISO13485 accreditation
8th Dec 20167:00 amRNSAppointment China Country Manager
8th Nov 20167:09 amRNSNew manufacturing facility in Doncaster
10th Oct 20163:53 pmRNSIssue of Equity
26th Sep 20167:00 amRNSChinese Manufacturing Agreement Signed
21st Sep 20167:00 amRNSNew Laboratory Opening
18th Aug 20167:00 amRNSInterim Results
27th Jul 20164:11 pmRNSTR-1: Notification of major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.